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Galactose and N-acetyl-D-galactosamine (Gal/GalNAc) inhibitable lectin of Entamoeba histolytica, 
a common protozoan parasite, has roles in pathogenicity and induction of protective immunity 
in mouse models of amoebiasis. The lectin consists of heavy (Hgl), light (Lgl), and intermediate 
(Igl) subunits. Hgl has lectin activity and Lgl does not, but little is known about the activity of Igl. 
In this study, we assessed various regions of Igl for hemagglutinating activity using recombinant 
proteins expressed in Escherichia coli. We identified a weak hemagglutinating activity of the protein. 
Furthermore, we found novel hemolytic and cytotoxic activities of the lectin, which resided in the 
carboxy-terminal region of the protein. Antibodies against Igl inhibited the hemolytic activity of 
Entamoeba histolytica trophozoites. This is the first report showing hemagglutinating, hemolytic and 
cytotoxic activities of an amoebic molecule, Igl.
Amoebiasis caused by infection with Entamoeba histolytica (E. histolytica) is a particularly problematic 
parasitic disease in both developing and developed countries. E. histolytica causes an estimated 50 million 
cases of dysentery, colitis and extraintestinal abscesses, resulting in 40,000 to 100,000 deaths annually1. 
Adherence of E. histolytica trophozoites to colonic mucins and host cells is essential for colonization, inva-
sion and subsequent pathogenesis, and is mediated by a galactose (Gal)- and N-acetyl-D-galactosamine 
(GalNAc)-inhibitable lectin2. The 260-kDa Gal/GalNAc inhibitable lectin is a heterodimer of transmem-
brane heavy subunit (Hgl, 170 kDa) and glycosylphosphatidylinositol (GPI)-anchored light subunit (Lgl, 
35/31 kDa) glycoproteins linked by disulfide bonds. Hgl contains a carbohydrate recognition domain 
(CRD) and is the key molecule in amebic adherence.
A GPI-anchored 150-kDa intermediate subunit (Igl, 150 kDa) is non-covalently associated with Hgl 
and also contributes to adherence3. A mouse monoclonal antibody (mAb) to Igl significantly inhibits 
adherence of E. histolytica trophozoites to erythrocytes and Chinese hamster ovary (CHO) cells, cytotox-
icity of trophozoites to CHO cells, and erythrophagocytosis of trophozoites4,5. Immunization of hamsters 
with native Igl and passive immunization with the mAb raised against Igl inhibits amebic liver abscess 
formation in hamsters6,7. Igl is also detected in the E. histolytica fraction that interacts with the brush 
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border of human enterocytes8. There are two isoforms of Igl, which are referred to as Igl1 and Igl2, and 
both are cysteine-rich proteins containing multiple CXXC motifs9. Two Igls also exist in E. dispar, which 
is morphologically indistinguishable from E. histolytica, but is non-pathogenic10. The expression level of 
the Igl1 gene is higher in E. histolytica than in E. dispar, whereas that of the Igl2 gene is comparable in the 
two species, suggesting that Igl1 may be more closely associated with the pathogenicity of E. histolytica.
Evaluation of the reactivity of sera from patients with amoebiasis to fragments of Igl1 shows sensitiv-
ities of 56%, 92%, and 97% for the N-terminal (N-Igl), middle (M-Igl), and C-terminal (C-Igl) regions, 
respectively11. All sera from asymptomatic patients react with M-Igl and C-Igl, which suggests that anti-
bodies to epitopes located in M-Igl and C-Igl may function to prevent invasion of trophozoites into host 
tissue. Indeed, a human mAb recognizing N-Igl does not inhibit amebic adherence to CHO cells, whereas 
another mAb reactive with M-Igl and C-Igl does inhibit adherence12. Therefore, it is important to identify 
the location of the domain related to amebic adherence in Igl.
Igl was identified as a lectin because it binds to a Gal-affinity column composed of p-aminophenyl-
β -D-galactopyranoside-Sepharose gel3. E. histolytica Igl has also been detected, in addition to Hgl and 
Lgl, in the protein fraction that binds to GalNAc-bovine serum albumin-coated magnetic beads13. 
However, the amino acid sequences of both Igls lack a known CRD of other lectins. Since the details of 
the function of Igl in amebic adherence are unclear, the molecular properties of Igl require investigation. 
In this study, we evaluated the lectin activity of Igl using a glycan array and also examined the in vitro 
effects of Igl in erythrocytes and Caco-2 cells. These studies revealed novel roles of Igl in the pathogenic-
ity of E. histolytica.
Results
Recombinant Igls. Full-length Igl (F-Igl, aa 14 to 1088), N-terminal (N-Igl, aa 14 to 382), middle 
(M-Igl, aa 294 to 753), and C-terminal (C-Igl, aa 603 to 1088) regions, and fragments of C-Igl of E. 
histolytica Igl1 with a His-tag at the N-terminus were expressed in E. coli, using the primer sets shown 
in Table 111. The recombinant proteins were purified using Ni columns, the buffer was changed to PBST, 
and the sample purities were confirmed by SDS-PAGE (Fig. 1b,c). These recombinant proteins were then 
used in further studies.
Hemagglutinating and hemolytic activities of recombinant proteins against horse red blood 
cells (HoRBCs). Since Igl is a lectin, we first wanted to clarify the region of Igl that is responsible 
for this activity. A commercial glycan array was used to check the lectin activity of F-Igl. As shown 
in Supplementary Fig. S1 online and Table  2, there was no significant affinity of F-Igl for the glycans 
on the array. Therefore, an established hemagglutinating assay was used to identify the region respon-
sible for the hemagglutinating activity of Igl. We first determined the optimum concentration of Igls 
for using in this study. As shown in Supplementary Fig. S2 online, a peanut lectin, PNA, showed its 
hemagglutinating activity at the concentration of 100 and 200 μ g/ml after 1 h of incubation with HoRBCs 
(2% v/v). At the same concentrations, F-Igl and C-Igl showed hemolytic activities after 18 h of incuba-
tions. Protein concentrations of 100 and 200 μ g/ml correspond to 0.836 and 1.67 μ M of F-Igl protein 
respectively. Therefore, we used 1 μ M proteins for further experiments in this study. HoRBCs (2% v/v) in 
PBS were mixed with F-Igl, N-Igl, M-Igl or C-Igl (Fig. 2). After the samples were mixed in a 96-well plate 
with a U-bottom, the plate was incubated at room temperature for one hour to evaluate the hemagglu-
tinating activities of the proteins (Fig. 2a). All recombinant Igl proteins showed some hemagglutinating 
activities, and to assess these activities the 96-well plate was tilted for 15 s and the lengths of deposited 
HoRBCs from the center to the edge were measured (Fig. 2b).
Incubation of samples up to 12 h was performed to examine differences over a longer incubation 
period. Both F-Igl and C-Igl showed hemolytic activities after 12 h of incubation, but N-Igl and M-Igl did 
not do so (Fig. 3). In the time-course assay, the hemolytic activity of F-Igl started to be observed after 
2 h of incubation and that of C-Igl after 5 h, while N-Igl and M-Igl showed no activity based on visual 
observation (Fig. 3a). To show that these results were really due to hemolysis of HoRBCs, the released 
hemoglobin (Hb) concentration was measured in the supernatant of incubated samples (Fig.  3b). As 
expected, Hb concentrations in F-Igl or C-Igl treated samples were significantly higher than that after 
PBST treatment, while those after N-Igl or M-Igl treatment were equivalent to PBST treatment (Fig. 3b).
We tried to narrow down the regions responsible for hemolytic activity by conducting the same 
hemolysis time-course assay using three fragments of C-Igl (C1-Igl, C2-Igl and C3-Igl) (Fig. 1). All the 
fragments showed similar hemolytic activities (Fig. 3c), which suggests that C2-Igl (aa 726–967) contains 
multiple active hemolytic sequences. These results showing that the C-terminal of Igl possesses hemolytic 
activity were supported by a comparison with the activity of NM-Igl (aa 14–753) (Supplementary Fig. S3 
online), a recombinant protein containing the N-terminus and middle of Igl with an 80 kDa molecular 
weight (Supplementary Fig. S3a and S3b online). In incubation of 1 μ M NM-Igl or C-Igl with HoRBCs, 
both proteins showed hemolytic activity, but C-Igl had twice the activity of NM-Igl after 8 h. This sug-
gests that the C-terminus of Igl has the main hemolytic activity (Supplementary Fig. S3c and S3d online).
Hemolytic activities of the recombinant proteins against B+ human red blood cells 
(HuRBCs). Glycans on the surface of the HoRBCs may have differed among sample lots because we 
could not assign the blood type of the HoRBCs. To show that the activities of the proteins were not 
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Figure 1. Recombinant Igl proteins used in this study. (a) Recombinant Igl proteins were constructed with 
a His-tag at the N-terminus. Full length (F-Igl), N-terminus (N-Igl), middle (M-Igl) and C-terminus (C-Igl) 
Igl1 were expressed in E. coli and purified using Ni columns. Three C-terminal fragments (C1-Igl, C2-Igl, 
C3-Igl) were also used in the study. Estimated molecular weights of each protein including the His-tag are 
shown. (b,c) The protein purity and amount were confirmed with SDS-PAGE using NuPAGE Novex Bis-Tris 
(4–12% gradient) gels with 1 μ g of each protein.
Primer Positionsa Sequence (5′ to 3′ )b Ref.
EhIgl-S14 40–59 CCCTCGAGGATTATACTGCTGATAAGCT *
EhIgl-S294 880–898 CCCTCGAGACAGAAGAAAATAAATGTA *
EhIgl-S603 1807–1827 CCCTCGAGGAAGGACCAAATGCAGAAGAT *
EhIgl-S726 2176–2195 CCCTCGAGCCATGTCCTGCAAAATGTAA **
EhIgl-S847 2539–2558 CCCTCGAGACATGTTCAGATAAAGACAC **
EhIgl-AS382 1129–1146 CCCTCGAGTTAAAGTTTGCATGGTCCATC *
EhIgl-AS753 2244–2259 CCCTCGAGTTATAGCCTTTGTTCAGTG *
EhIgl-AS846 2521–2538 CCCTCGAGTTATGCACATTTATCATCACA **
EhIgl-AS967 2884–2901 CCCTCGAGTTAACATTTAGTACATTCTTC **
EhIgl-AS1088 3247–3264 CCCTCGAGTTAAATGCCTTTAGCTCCATT *
Table 1.  Oligonucleotide primers used in this study. aNucleic acid numbering is based on the E. 
histolytica Igl1 gene sequence (AF337950). bNucleotides added for cloning and translation termination are 
underlined. *Tachibana et al., J. Clin. Microbiol. 2004;42:1069-1074. **This study.
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specific for HoRBCs, we conducted the same study using B+ human red blood cells (HuRBCs), in which 
some glycans on the surface had galactose residues at the terminus of the glycans (Fig. 4). F-Igl and C-Igl 
showed hemolytic activities with HuRBCs (Fig. 4a) that were similar to the results for HoRBCs (Fig. 3a).
Sialic acids on RBCs may also affect the hemolytic activity of the Igl proteins. To examine this possi-
bility, we treated HuRBCs with sialidase prior to the assay. Sialidase treatment of HuRBCs did not affect 
the hemolytic activities of F-Igl and C-Igl over 12 h of incubation (Fig.  4a). F-Igl and C-Igl induced 
hemolysis in this assay and that the results were not affected by the presence of sialic acids on HuRBCs. 
Interestingly, a galactose-recognizing lectin, PNA, showed no hemolytic activity at the same concen-
tration as F-Igl or C-Igl (Fig. 4b). This was confirmed by microscopic observations showing that no or 
few HuRBCs remained in samples after 8 h of incubation with F-Igl or C-Igl, whereas more HuRBCs 
remained in other samples (Fig. 4c).
We also assessed whether the hemolytic activity could be inhibited by monosaccharides. Mixing of 
tenfold higher concentrations of galactose or mannose with F-Igl prior to mixing with HuRBCs produced 
no significant difference in visual observation and released Hb concentrations (Fig.  4d,e). Collectively, 
these results indicate that the hemolytic activities of the Igl proteins were not specific to HoRBCs and 
were unaffected by sialic acid, galactose, and mannose residues on the surface of HuRBCs.
Cytotoxic activities of recombinant Igl proteins against human colon carcinoma Caco-2 
cells. The results above show that Igl has novel hemolytic activity with HoRBCs or HuRBCs. To eval-
uate whether Igl is also cytotoxic, human colonic epithelial Caco-2 cells were cultured with recombi-
nant Igl proteins. Caco-2 cells proliferated with a cobblestone appearance after 12 or 24 h of incubation 
Number Glycans
High concentration Low concentration
S/N Sa Nb S/N Sa Nb
1 N-glycan M9 1.2 294 255 1.1 251 236
2 NA2 1.1 278 256 1.1 256 241
3 A2 1.1 265 243 1.1 249 236
4 NAF2 1.1 263 243 1.1 256 236
5 NA3 1.0 264 253 1.0 259 250
6 A3 1.1 281 257 1.1 252 236
7 NA4 1.1 277 258 1.1 260 246
8 O-glycan sTn 1.0 262 258 1.0 253 250
9 T 1.0 254 250 1.0 266 263
10 GAG Heparin 1.2 311 249 1.2 290 245
11 De2SHep 1.1 278 243 1.1 268 248
12 De6SHep 1.1 256 237 1.0 260 250
13 DeNSHep 1.0 246 240 1.0 254 258
14 DeNS/AcHep 1.0 253 253 1.0 259 256
15 Lewis type Lea 1.0 259 248 1.0 255 243
16 LeX 1.1 261 243 1.0 255 250
17 sLea 1.1 277 260 1.0 253 248
18 sLeX 1.0 277 267 1.0 267 257
19 Lac Lac 1.1 263 239 1.1 285 248
20 3SL 1.1 245 229 1.1 272 247
21 6SL 1.2 278 239 1.1 274 246
22 3SLNAc 1.1 261 242 1.1 278 256
23 6SLNAc 1.1 265 249 1.0 278 265
24 LNT 1.0 256 244 1.0 273 260
25 LNnT 1.0 252 247 1.1 268 249
26 ABO type A 1.1 260 243 1.0 258 247
27 B 1.0 252 251 1.0 252 247
28 O 1.0 264 260 1.0 260 253
Table 2.  Affinity of recombinant F-Igl for 28 glycans.c aSignal. bNoise. cRefer to Supplementary Fig. S1 
online for details.
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with PBST, N-Igl, M-Igl or medium, but became round and died when cultured with F-Igl or C-Igl 
(Fig.  5a). There was a significant decrease in the number of cells remained on the plate in incubation 
with F-Igl or C-Igl (Fig.  5b). The viability of the cells was assessed by the trypan blue exclusion assay. 
Attached and detached cells were confirmed as dead cells in the F-Igl treated group after 12 h of incuba-
tion (Supplementary Fig. S4 online).
E. histolytica has contact-dependent cytotoxicity against host cells and contact-dependent transfer 
of E. histolytica lectins to host cells can occur14. Therefore, we examined if the recombinant Igl proteins 
could attach to Caco-2 host cells by incubating proteins labeled with Alexa Fluor 488 with Caco-2 cells 
(Fig.  5c). Interestingly, F-Igl attached strongly to the entire round shaped cell and the signal was also 
observed at the edge of the adherent cells (Fig.  5d). Igl-treated cells showed a significant increase in 
Figure 2. Hemagglutinating activities of Igl proteins in horse red blood cells (HoRBCs). Fifty microliters 
of 2 μ M recombinant Igl proteins were incubated with 50 μ l of 2% (v/v) HoRBCs in PBS for 1 h.  
(a) Images of HoRBCs left to stand and tilted in a 96-well plate after 1 h of incubation with recombinant 
Igls. Representative images are shown from five experiments each. (b) Bar graph showing lengths of 
the HoRBCs from the center to the edge after the plate was tilted. Data are the mean + SD from five 
independent experiments. **p < 0.01 for multiple comparisons (Dunn’s test).
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fluorescence signal intensities compared to PBST-treated cells (Fig.  5e: PBST: median 19.0 (IQR 44.4), 
F-Igl: 321.7 (270.6), N-Igl: 59.6 (40.4), M-Igl: 45.7 (69.2), C-Igl: 68.9 (134.2)). The higher median values 
for F-Igl- and C-Igl suggest that these proteins attached to Caco-2 cells (Fig. 5e) and thereby caused cell 
death. The lower attachment of C-Igl compared to that of F-Igl may be due to the short (1 h) incubation. 
A delay in the activity of C-Igl compared to F-Igl is consistent with the results in the hemolytic (Figs 3 
and 4) and cytotoxicity (Fig. 5) assays. Collectively, our results show that Igl has novel hemagglutinating, 
hemolytic and cytotoxic activities in vitro.
Inhibition of hemolytic activity of Entamoeba histolytica trophozoites by anti-Igl monoclonal 
antibodies. To assess whether these activities reflect the activities of intact Igl on E. histolytica tro-
phozoites, monoclonal antibodies recognizing N-Igl (XEhI-28) and M/C-Igl (XEhI-H2) were incubated 
with the trophozoites prior to the hemolytic assay (Fig.  6). Significant inhibition in hemolytic activ-
ity was observed when the trophozoites were pre-incubated with anti-Igl antibodies (Fig.  6b). About 
45% (45.3 ± 8.5) inhibition in the activity was observed when the XEhI-H2 antibody-treated group was 
compared with the isotype control-treated group. XEhI-28 antibody-treated group showed around 15% 
(14.1 ± 7.9) inhibition compared with control IgG-treated group indicating that middle or C-terminus 
region of intact Igl on E. histolytica trophozoites has the main hemolytic activity (Fig. 6c).
Discussion
The E. histolytica lectin consists of three subunits, Hgl, Lgl and Igl, of which Hgl and Igl have lectin 
activities15. Little is known about the lectin activity of Igl, except that this protein binds to a Gal-affinity 
Figure 3. Time-course of hemolytic activities of Igl proteins. Fifty microliters of recombinant Igl proteins 
(2 μ M) were incubated with 50 μ l of 2% (v/v) HoRBCs in PBS for the indicated periods.  
(a) Images of HoRBCs in a 96-well plate after the indicated incubation periods with Igls. (b) Concentrations 
of hemoglobin (Hb) released in the supernatant of samples incubated for 8 h. Data are the mean + SD from 
five independent experiments. **p < 0.01 for PBST vs. Igl treatment (Dunnett’s test). (c) Images of HoRBCs 
in a 96-well plate after the indicated incubation periods with C-Igl, C1-Igl, C2-Igl and C3-Igl.
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column3. In this study, we planned to determine the regions of Igl that have lectin activity, but glycan 
array results did not indicate any lectin activity of Igl and the hemagglutinating activity of the protein 
was weak. However, novel hemolytic activity was found that was associated with the C-terminus of Igl, 
and the protein was also cytotoxic in Caco-2 cells. Furthermore, hemolytic activity of E. histolytica tro-
phozoites was inhibited by monoclonal antibodies against Igl. To our knowledge, this is the first study to 
show that E. histolytica Igl lectin has hemagglutinating, hemolytic and cytotoxic activities.
Involvement of Gal/GalNAc lectin of E. histolytica in cytotoxicity towards host cells has been studied 
for several decades. This is because the activity can be inhibited by GalNAc16 or monoclonal antibody 
raised against Hgl17. The E. histolytica membrane also has hemagglutinating activity toward human A+ 
red blood cells18. However, despite Hgl having a CRD19, involvement of Hgl in this activity has not 
been examined. The unexpected hemagglutinating, hemolytic, and cytotoxic activities of Igl suggests 
the presence of a CRD, but we were not able to identify a CRD in Igl using a glycan array (Table 2 and 
Supplementary Fig. S1 online), even though Igl binds to a Gal-affinity column3. This might be because 
the affinity of Igl for glycans on the array is weak. Hgl has low affinity for a single GalNAc residue com-
pared to that for multiple GalNAc-attached neoglycoproteins20,21, and this may also be the case for Igl. 
In fact, in our preliminary study, we could observe affinities of F-Igl and C-Igl toward (GalNAc)19-HSA 
(Supplementary Fig. S5a online). However, all recombinant Igl proteins had also high affinities toward 
Figure 4. Hemolytic activities of Igl proteins in B+ human red blood cells (HuRBCs). Fifty microliters 
of recombinant Igl proteins (2 μ M) were incubated with 50 μ l of 2% (v/v) HuRBCs in PBS for the indicated 
periods. (a) Images of HuRBCs in a 96-well plate after the indicated incubation periods with Igls or 
PNA. HuRBCs used in this study were treated with PBS or sialidase. (b) Concentrations of hemoglobin 
(Hb) released in the supernatant after incubation for 8 h. Data are the mean + SD from five independent 
experiments. *p < 0.05 for PBS treatment vs. sialidase treatment (Student’s t-test). (c) Microscopic 
observations of HuRBCs after incubation for 8 h with Igls or PNA. Bars indicate 20 μ m. (d,e) Galactose or 
mannose was mixed with F-Igl prior to mixing with HuRBCs. No significant differences among samples 
were observed visually during the incubation period or in the concentrations of released Hb after 8 h of 
incubation (Dunn’s test).
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Figure 5. Cytotoxic activities of Igl proteins against human colon carcinoma Caco-2 cells. (a,b) 
Caco-2 cells were cultured in a 96-well plate for 24 h prior to incubation with recombinant Igl proteins 
(2 × 104/100 μ l/well). One-hundred microliters of Igl proteins (2 μ M) or medium were added and incubated 
for an additional 12 or 24 h. (a) Images of Caco-2 cells in a 96-well plate after the indicated incubation 
periods with Igls taken with an EVOS-XL microscope. Bars indicate 50 μ m. (b) Line graph of the number 
of Caco-2 cells remaining in the well after 0, 12 and 24 h of incubation. Data are the mean + SD from five 
independent experiments. *p < 0.05, **p < 0.01 for medium vs. Igl treatment (Dunnett’s test). (c–e) Caco-2 
cells were spread into an ibidi 6-well flow chamber and incubated with Igl proteins. (c) Alexa Fluor 488 
fluorescence of Caco-2 cells treated with PBST, F-Igl, N-Igl, M-Igl, or C-Igl. Cells were isolated in a bright 
field image with Hoechst 33342 staining (inset in PBST treated cells) for measuring the median fluorescence 
intensity of each cell in further studies. Open arrowheads and an open arrow indicate round cells and the 
edge of an attached cell, respectively, for which strong F-Igl attachment was observed. The open bar indicates 
20 μ m. (d) Fluorescence signal intensities of a F-Igl treated cell measured as shown in panel C with closed 
arrowheads indicating the edges of the cell. (e) Quantitative comparison of fluorescence intensities detected 
by fluorescence microscopy. Fifty cells were randomly selected for each group. The median fluorescence of 
each group is shown with interquartile ranges. *p < 0.05, **p < 0.01 between the groups (Wilcoxon signed-
rank test).
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HSA (Supplementary Fig. S5b online). More intensive studies need to be done to conclude the region of 
Igl having the lectin activity.
Two isoforms of Igl are also present in non-pathogenic E. dispar, with amino acid sequence identities 
of 75–76% for Igl1 and 73–74% for Igl2 between E. histolytica and E. dispar. However, the expression 
level of Igl1 is higher in E. histolytica than in E. dispar10. This suggests that Igl1 may have a role in the 
pathogenicity of Entamoeba, but it is important to emphasize that Igl was originally identified using 
monoclonal antibodies specific for E. histolytica22. Regardless, it will be important to examine whether 
the expression level of Igl correlates with the virulence of E. histolytica in more detail.
The name “histolytica” was given to this parasite because it destroys host tissues in a contact-dependent 
manner. One of the best-known amoebic proteins responsible for this effect is amoebapore, a pore-forming 
protein that also possesses cytolytic activity but not hemolytic activity towards human or rabbit eryth-
rocytes23,24. Amoebapore is present in amoeba granules and requires stimulatory signals for its secretion 
for contact-mediated cytolysis of host cells. The primary function of the protein is thought to be the 
killing of ingested bacteria or cells inside their digestive vacuoles24,25. Furthermore, a higher concentra-
tion of amoebapores (>10–100 μ M) is required for their cytotoxic activities26. In contrast, 1 μ M Igl was 
required for activity in the present study. Igl1 and Igl2 are co-localized on the surface and cytoplasm of 
the parasite, but different localization patterns in intracellular vacuoles have also been detected10,12. E. 
histolytica phagosomes contain Igl and the quantity of Igl varies during maturation of the phagosome27,28. 
Therefore, the hemolytic and cytolytic activities of Igl may also be important in the killing of ingested 
cells in the phagosome. In another study, an Entamoeba histolytica strain lacking amoebapore-A (the 
G3 strain) showed reduced target cell destruction, cytotoxic and hemolytic activities compared with a 
parental HM-1:IMSS strain29, which indicates that expression of amoebapore-A is required for the hemo-
lytic activity of the HM-1:IMSS strain. It is of note that, in the same study, an avirulent Rahman strain 
showed a similar phenotype to that of the G3 strain, even though the Rahman strain expressed similar 
protein levels of amoebapore-A compared with the HM-1:IMSS strain. This indicates involvement of 
other factors in these phenotypes.
Figure 6. Inhibition of hemolytic activity of Entamoeba histolytica trophozoites by anti-Igl monoclonal 
antibody treatments. Ten micrograms of anti-Igl antibodies (XEhI-28 and XEhI-H2) or control antibodies 
were incubated with 5 × 105 E. histolytica trophozoites prior to hemolytic assay. (a) Images of HoRBCs 
in a 96-well plate after the indicated incubation periods with trophozoites or PBS. (b) Concentrations of 
hemoglobin (Hb) released in the supernatant after incubation for 1 h. Data are the mean + SD from three 
independent experiments. *p < 0.05, **p < 0.01 for anti-Igl mAb vs. isotype control Ab treatment (Student’s 
t-test). (c) Percentage inhibition of hemolytic activity of the trophozoites by anti-Igl mAb treatments. The 
values are 14 ± 7.9% for XEhI-28/IgG and 45.3 ± 8.5% for XEhI-H2/IgM.
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The amino acid sequence of amoebapore-A30 was aligned with those of the C1-, C2-, and C3-Igls to 
obtain information on the hemolytic activity of Igl (Supplementary Fig. S6 online). There were some sim-
ilar sequences in amoebapore-A and the C-Igl fragments, but no conserved motif that might contribute to 
Igl activity. A unique pore-forming protein from Acantamoeba culbertsoni has recently been described31 
as an acanthaporin of the saposin-like protein (SAPLIP) family, similarly to amoebapore-A. As shown in 
Supplementary Fig. S7 online, this protein also had no conserved domain with the C-Igl fragments, espe-
cially with the C2-Igl sequence, in which the hemolytic activity of Igl seemed to reside (Fig. 3c). A marine 
invertebrate, Cucumaria echinata, has a Ca2+-dependent Gal/GalNAc lectins (CEL-I-IV)32, among which 
CEL-III exhibits strong hemolytic and cytotoxic activities33,34. Since E. histolytica Igl also possesses hemo-
lytic and cytotoxic activities, we compared the CEL-III amino acid sequence35 with those of the C-Igl 
fragments (Supplementary Fig. S8 online). Clusters of homologous amino acid sequences were found 
(Supplementary Fig. S8a-c online) with conserved CX8C motifs among these sequences (Supplementary 
Fig. S8, boxes ①–⑦ online). An amino acid important for the hemolytic activity of CEL-III, Arg408, is 
in one of these CX8C motifs. Comparison of Igl with Hgl showed that Hgl does not have CX8C motifs in 
the comparable region (Supplementary Fig. S8d online). F-Igl contains 9 CX8C motifs and N-Igl, M-Igl, 
and C-Igl have 1, 1, and 7 motifs, respectively. The C2-Igl and C3-Igl fragments contain several motifs 
(Supplementary Fig. S8a-c online), but C1-Igl has only one. More importantly and interestingly, these 
motifs exist in E. dispar Igl1 and Igl210. As mentioned above, the expression level of Igls might correlate 
with the virulence of E. histolytica. Thus, a further study is needed to determine whether these motifs 
are important for the activities of Igl.
There is also a need to determine if Igl possesses the hemolytic and cytotoxic activities of the parasite 
and has a role at the site of infection in vivo. These findings will emerge from future studies using atten-
uated E. histolytica that lacks Igl protein.
Methods
Expression and refolding of recombinant F-Igl, N-Igl, M-Igl, C-Igl and fragment C-Igl pro-
teins. E. coli BL21 Star(DE3)pLysS cells (Invitrogen) or ECOSTM competent BL21(DE3) cells (Nippon 
Gene Co.) were transformed with plasmids containing a DNA fragment coding F-Igl, N-Igl, M-Igl, 
C-Igl or C-Igl fragments (C1-, C2- or C3-Igl) ligated with a pET19b vector (Novagen), as described 
previously11. The primer sets are shown in Table  1. The gene-transformed BL21 Star(DE3)pLysS cells 
were cultured in 2 ml of LB medium containing ampicillin (100 μ g/ml) and chloramphenicol (34 μ g/ml) 
in a multi-shaker incubator at 37 °C overnight. BL21(DE3) cells were cultured under the same condi-
tions, except for the addition of chloramphenicol. The turbid culture was transferred to 2 × YT medium 
and incubated at 37 °C until the optical density (OD600) reached 0.6. Isopropyl-β -D-thiogalactopyrano
side (0.25 mM) was added to the culture, incubated at 22 °C for 20 h, and centrifuged at 6500 × g for 
15 min. The pellet of E. coli was washed with 1 × IB Wash Buffer (20 mM Tris-HCl pH 7.5, 10 mM 
EDTA, 1% Triton X-100) from a Protein Refolding Kit (Novagen) and resuspended in the same buffer 
supplemented with Benzonase Nuclease (Sigma, 1 μl/100 ml culture). For BL21(DE3) cells, 100 μ g/ml 
of Lysozyme (Thermo) were added to the samples and incubated at 30 °C for 15 min. Sonication of the 
samples was conducted using a Sonifier SLPe Digital Ultrasonic Homogenizer (Branson) or a USP-400 A 
ultrasonic breaker (Shimadzu Co., Ltd.). The samples were centrifuged at 10,000 × g for 10 min at room 
temperature. C2-Igl recombinant protein was obtained from the supernatant of homogenized samples 
and applied to a Ni column without solubilizing and dialyzing steps. Solubilization and refolding of other 
recombinant proteins were conducted according to the instructions provided with the Protein Refolding 
Kit (Novagen).
Ni column purification of recombinant proteins. The His-tagged refolded proteins were further 
purified using a Ni column. Five milliliters of the protein solution was batched with 1 ml of Ni-NTA 
agarose (Qiagen) at 4 °C overnight. The mixtures were loaded onto hand-made columns. The column 
was washed three times with 1 ml of PBS containing 10 mM imidazole. Recombinant proteins were 
eluted with PBS containing 200 mM imidazole (1 ml/fraction). The fractions containing recombinant 
proteins were pooled and buffers were changed to PBST (PBS with 0.05% Tween 20) with Amicon Ultra 
Ultracel-10 K (Millipore) before further use. The protein concentration was determined using BioRad 
protein assay reagent.
SDS-PAGE and Coomassie Brilliant Blue staining of purified recombinant proteins. Recombinant 
proteins (1 μ g each) were mixed with a one-third volume of SDS sample buffer (Invitrogen) and subjected 
to SDS-PAGE using a NuPAGE Novex Bis-Tris (4–12% gradient) gel in reducing condition. Electrophoresis 
was conducted for 40 min at 200 V. The gel was treated with SimplyBlue Safe stain solution (Invitrogen) and 
incubated until blue bands appeared on the gel.
Assay of lectin activity using a glycan array. The lectin activity of F-Igl was measured using a 
glycan array (Glycan Array I, BS-X1731, Sumitomo Bakelite Co., Japan). Seventy microliters of 200 μ g/ml 
F-Igl was loaded on the array and incubated with mouse anti-His tag antibody (70796–3, Novagen) and 
Cy5 goat anti-mouse IgG (H + L) antibody (A105247, Life Technologies), following a protocol supplied 
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by Sumitomo Bakelite Co. Affinity signals were measured by the fluorescence of Cy5 and data are expressed 
as a signal/noise (S/N) value. S/N values > 3 were considered to indicate significant binding of F-Igl 
to glycans. The glycan structures coated on the array are shown in Supplementary Fig. 1b online. 
This array included areas of high (0.5 mg/ml GAGs, 0.2 mM N-glycans, and 1.0 mM other glycans) and low 
(0.1 mg/ml GAGs, 0.04 mM N-glycans, and 0.2 mM other glycans) concentrations of glycans.
Hemagglutination and hemolytic assays using recombinant lectins. Fifty microliters of 
recombinant Igls or PNA lectin (2 μ M each) were loaded onto a 96U microwell plate (Nunc). Horse or 
B+ human red blood cells (HoRBCs or HuRBCs) were prepared from horse blood in Alsever’s buffer 
(Nippon Biotest Laboratories Inc., Japan) or purchased from Tennessee Blood Services (Memphis, TN). 
Two percent (v/v) RBCs in PBS were prepared and 50 μ l/well of the RBC solutions were added to the 
lectin-preloaded wells at room temperature. To assess weak hemagglutinating activities, the 96 multiwell 
plate was tilted for 15 s and the lengths of deposited HoRBCs from the center to the edge were measured. 
The results are shown as the mean of 5 experiments with a standard deviation (SD). To evaluate the 
effect of sialic acids on RBCs on hemolytic activity of the lectins, 1% (v/v) sialidase from Vibrio chol-
erae (Roche Applied Science) or PBS was added to 2% (v/v) HuRBCs and incubated at 37 °C overnight. 
Sialidase- or PBS-treated HuRBCs were washed with PBS twice before the assay. Galactose or mannose 
(20 μ M) was added to 50 μ l of F-Igl (2 μ M) to assess whether the activities were mediated by the lectin 
domain of the protein. Fifty microliters of 2% (v/v) HuRBCs was added and the samples were incu-
bated at room temperature for up to 8 h. Hemagglutinating and hemolytic activities of the lectins were 
observed after RBC loading and images were taken at several time points. Hemolytic activities of the 
lectins were further assessed by observing RBCs under an EVOS XL microscope (Invitrogen).
Hemolytic assay using Entamoeba histolytica trophozoites. Trophozoites of E. histolytica 
(HM-1:IMSS strain) were grown in TYI-S-33 medium at 37 °C. Monoclonal antibodies against Igl (XEhI-
28 and XEhI-H2) and isotype controls12 were prepared and used to evaluate the role of intact Igl in the 
hemolytic activity. This assay was conducted as previously described36 with slight modifications. Briefly, 
5 × 105 trophozoites were treated with 10 μ g of antibodies or PBS and incubated at 4 °C for 1 h. After 
washing the trophozoites with PBS, the trophozoites were mixed with 1% HoRBCs in 100 μ l PBS and 
incubated at 37 °C for 1 h. The cell suspension was sedimented at 2000 rpm for 5 min and the concentra-
tion of hemoglobin in the supernatant of the sample was determined.
Detection of released hemoglobin concentration. To quantify the hemolytic activity of each 
recombinant protein, a Hemoglobin B Test Kit (Wako, Osaka, Japan) was used to measure the concen-
tration of hemoglobin in the supernatants of the RBCs and recombinant protein or trophozoite mixtures 
described above after incubation for 8 h or 1 h. The results are expressed as the mean of 5 or 3 experi-
ments with SD.
Cytotoxic assay using recombinant lectins. Caco-2 cells (ATCC, HTB-37) were cultured in MEM 
basic medium (Gibco) supplemented with Earle’s salts, L-glutamine and 20% fetal bovine serum. After 
detachment with 0.25% Trypsin-EDTA (Gibco), the cells were cultured in a 96-well plate at approxi-
mately 2 × 104 cells/100 μ l/well at 37 °C under 5% CO2 for 24 h. One hundred microliters of 2 μ M recom-
binant Igl, PBST or medium containing 200 units/ml penicillin G and 200 μ g/ml streptomycin (Wako, 
Japan) was added and the cells were incubated for an additional 12 or 24 h under the same conditions. 
The cells were trypsinized and harvested after 0, 12 or 24 h of incubation and the number of cells per 
well was counted. The results are shown as the mean of 5 experiments with SD.
Attachment of recombinant Igl lectins to Caco-2 cells. Caco-2 cells (1 × 105 cells/100 μ l/well) 
were spread into a μ -Slide VI0.4 ibiTreat 6-well flow chamber (ibidi GmbH, Germany) and incubated 
at 37 °C under 5% CO2 for 24 h. Cells were washed 3 times with 100 μ l of PBS and treated with 100 μ l 
of PBST, 1 μ M of F-Igl, N-Igl, M-Igl or C-Igl, or control EMEM medium supplemented with 100 ng/ml 
Hoechst 33342 (Life Technologies, CA), 100 units/ml penicillin G and 100 μ g/ml streptomycin (Wako, 
Japan). The samples were incubated at room temperature in the dark for 1 h. After washing with PBS, the 
cells were fixed with 100 μ l/well of 4% paraformaldehyde/glutaraldehyde solution at room temperature 
in the dark for 15 min. The cells were washed again with PBS three times, followed by incubation with 
100 μ l of 1:1000 diluted His-tag monoclonal antibody (mouse IgG1, Novagen, 70796–3) at room temper-
ature in the dark for 1 h. After washing with PBS, the cells were stained with a 1:1000 diluted Alexa Fluor 
488 goat anti-mouse IgG1 antibody (Life Technologies, A21121) at room temperature in the dark for 
1 h. The samples were then mounted with 100 μ l of ProLong Gold antifade solution (Life Technologies) 
after washing with PBS three times. Alexa Fluor 488 and Hoechst 33342 fluorescence of the stained cells 
were captured under a fluorescence microscope (Ti-E, Nikon, Japan) equipped with a ×40 objective lens 
(Nikon) and a CCD camera (ORCA-R2, Hamamatsu Photonics, Japan). Fifty cells in each group were 
randomly selected, and Alexa Fluor 488 fluorescence of these cells was analyzed using NIS-Elements 
Advanced Research imaging software (Nikon). Median fluorescence intensities were calculated with an 
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interquartile range (IQR), compared among the groups, and plotted using GraphPad Prism6 software 
(GraphPad Software, Inc., La Jolla, CA).
Statistical analysis. For multiple comparisons, an ANOVA with Dunn’s test or Dunnett’s test was 
employed. A Student’s t-test and a Wilcoxon signed-rank test were also used in statistical analyses, with 
P < 0.05 considered significant.
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